$ Value
$401K
Shares
11,659
Price
$34
Filed
Aug 12
Insider
Name
Freund John Gordon
Title
—
CIK
0001296771
Roles
Transaction Details
Transaction Date
2025-08-08
Code
S
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
23,129
Footnotes
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.27 to $34.535, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The shares are held by the John Freund Family Partnership IV, L.P. ("Freund LP"). The Reporting Person is the trustee and beneficiary of the The John G. Freund Revocable Trust u/a/d 6/26/01 which serves as the general partner of Freund LP. The Reporting Person disclaims beneficial ownership of the shares held by Freund LP except to the extent of his proportionate pecuniary interest therein. | The shares are held by Skyline Venture Management V, LLC. John G. Freund and Yasunori Kaneko are managers of Skyline Venture Management V, LLC. These individuals share voting and investment power over the shares held by Skyline Venture Management V, LLC. The Reporting Person disclaims beneficial ownership of all the shares held by Skyline Venture Management V, LLC except to the extent of his proportionate pecuniary interest therein.
Filing Info
Freund John Gordon's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-08-08 | SIBN | ▼ | $194K |
| 2025-08-08 | COLL | ▼ | $401K |
| 2025-06-09 | COLL | M | $202K |
| 2025-06-09 | COLL | ▼ | $202K |
| 2025-06-09 | COLL | M | $0 |
| 2025-06-05 | SIBN | A | $0 |
| 2025-05-15 | COLL | A | $0 |
Other Insiders at COLL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Karnani Vikram
President and CEO
|
— | — | 2026-02-10 |
|
Dreyer Scott
EVP & Chief Commercial Officer
|
— | — | 2026-02-10 |
|
Smith Thomas B
EVP and Chief Medical Officer
|
— | — | 2026-02-10 |
|
Tupper Colleen
EVP & Chief Financial Officer
|
— | — | 2026-02-10 |
|
Dieter David
EVP & General Counsel
|
— | — | 2026-03-17 |